E FOR L AIM PUBLIC COMPANY LIMITED March 31, 2016 FINANCIAL HIGH - PowerPoint PPT Presentation

E FOR L AIM PUBLIC COMPANY LIMITED March 31, 2016

FINANCIAL HIGH LIGHT Mar 08, 2016 Paid-Up Capital (THB Million) 690.0 Par Value (THB/share) 0.075 Dividend Payout (%) >40% Free Float (%) 79.30% Book Value (THB/share) 0.14 Stock data 26-Week Range (THB) 1.17/0.50 Sector MAI P/E (x) 31.05 P/BV (x) 5.00 2

DISCLAIMER This presentation has been prepared by EFORL AIM PUBLIC COMPANY LIMITED (“EFORL”) and is circulated for the purpose of genera l information only, it is not intended for any specific person or purpose and does not constitute a recommendation regarding the securities of EFORL. No warranty (expressed of implied) is made to the accuracy or completeness of the information. All opinions and estimations included in this report constitute our judgement as of this date and subject to change without prior notice. EFORL disclaims any responsibility or liability whatsoever arising which may be brought against or suffered by any person as a result of reliance upon the whole or any part of the contents of this presentation and neither EFORL nor any of its affiliated companies and their respective employees and agents accept liability for any errors, omissions, negligent or otherwise, in this presentation and any inaccuracy herein or omission here from which might other arise. Forward-looking Statements The information communicated in this presentation contains certain statements that are or may be forward looking. These statements typically contain words such as “will”, “expects” and “anticipates” and words of similar import. By their nature, forward looking state ments involve a number of risks and uncertainties that could cause actual events or results to differ materially from those described in this presentation. Factors that could cause actual results to differ include, but are not limited to, economic, social and political conditions in Thailand, including environmental regulations and compliance costs; fluctuations in foreign currency exchange rates; interest rate trends, cost of capital and capital availability; the anticipated demand and selling prices for EFORL’s products and services; competition from other companies a nd venues; shifts in customer demands; changes in Cost of Goods Sold; changes in selling, general & administrative expenses, including employee wages, benefits and training, governmental and public policy changes; EFORL’s ability to be and remain competitive; EFORL’s of futur e receivables; ; Food and Drug Administration (“FDA”) and environmental compliance and remediation. Should one or more of these uncertainties or risks, among others, Medical tools and equipment cost, logistic cost, after-sales service cost, advertisement cost, materialize, actual results may vary materially from those estimated, anticipated or projected. Specifically, but without limitation. Although EFORL believes that the expectations of its management as reflected by such forward-looking statements are reasonable based on information currently available to us, no assurances can be given that such expectations will prove to have been correct. You should duly rely on such statements. In any event, these statements speak only as of the date hereof, and EFORL undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise. 3

GLOSSARY EFORL E for L Aim Public Company Limited SPACEMED Spacemed Co., Ltd. SIAM SNAIL Siam Snail Co., Ltd. THAT’SO That’so Asia Corporation Co., Ltd. WCI Wuttisak Cosmetic Inter Co., Ltd. WCIG Wuttisak Clinic Intergroup Co., Ltd. WCIH WCI Holding Co., Ltd. WGI Wuttisak Grand Inter Co., Ltd. WPI Wuttisak Pharmacy Inter Co., Ltd. WS W.S. Surgery 2014 Co., Ltd. Wuttisak WCI Holding Co., Ltd. Group of companies 4

EFORL GROUP OVERVIEW 5

 Purchased 51% of Siam Snail Co., Ltd., which has the formal and solely license to produce/operate the EFORL HISTORY special and concentric filtrate of snails from Chulalongkorn University Intellectual Property Institute (see www.cuipi.chula.ac.th. ) in June.  Increase Siam Snail Co., Ltd. registered capital to THB 20 Million in July.  Divest in WCIH by sold out shares 9.83% for reducing a Long-term debt burdens in September  The paid-up capital was raised to THB (Nine Million shares) and in October (8.8 Million 920 Million by July. shares). – Early Harvesting  Mr.Teerawut was appointed as a CEO  A Paradigm Shifts for ihealth products as the E-Health and changed direction of the company to total solutions On-line sales ( eforl.onlineshop.cente r ) focus on Medical Product in August. in October.  Shifted the core business from media advertising to medical health products and changed the name to “ E for L Aim” in September.  Purchased 100% of Spacemed Co., Ltd. in September.  Purchased 18% of That’so Asia Corporation Co., Ltd. in June.  Set up WCIH with THB 1,000 million (and Surplus THB 1,500 Million) synergies two groups of a partner (Founders and a Local Investment Fund) paid-up capital for purchase 100% of WCIG in September. An EFORL former name is Absolute Impact  With two groups of a partner, purchased all PCL. , Established by Mr.Prin Chanatranond in shares of WCIG thorough WCIH in December. 6 August with the paid-up capital THB 50 Million.

 Mar.30, 2016: Siam Snail had planned for a Grand Opening Snail semi-natural farm at The Eastern Outskirt of Bangkok.  Feb.3, 2016: WCIH was appointed to Maybank KimEng Securities (Thailand) Plc. And CIMB Securities (Thailand) Co., Ltd. to be the Financial Advisory (FA) for funding and to be a listed company within Q3 of 2016.  Dec.24, 2015: WCIG at Siam square branch had been accredited by Joint Commission International (JCI), which has evaluated the Ambulatory Care Organization and found it to meet the International Health Care Quality Standards for patient care and organization management.  Feb.29, 2016: EFORL was appointed from BORSAM Biomedical Instruments Co., Ltd. to be the solely and exclusive agent for selling Portable ECG machines thorough Thailand.  Nov.28, 2015: Siam Snail Co., Ltd. had been granted Gold Prize from Seoul International Invention 2015 at Seoul, Korea.  Oct.19, 2015: EFORL appointed Mr.Kriangsak Prateepvisut 7 as Chief Financial Officer (CFO).

EFORL GROUP Updated as of October 2015 100% 50.17% 51% 18% Spacemed WCIH That’s so Asia Corporation Spacemed Co., Ltd. WCI Holding Co., Ltd. Siam Snail Co., Ltd. Co., Ltd. 100% Wuttisak Clinic Inter Group Co., Ltd. 99.97% 99.99% 99.97% WGI 99.98% WSS WCI WPI Wuttisak Cosmetic Wuttisak Pharmacy Wuttisak Grand W.S. Surgery 2014 8 Inter Co., Ltd. Inter Co., Ltd. Inter Co., Ltd. Co., Ltd. Healthy Drinks Healthy Food Beauty Services

Revenue (MB.)** 62% EFORL Y2015 Y2014 MEDICAL 1,911 1,181 EQUIPMENT Revenue (MB.)** SPACEMED Y2015 Y2014 211% 4,504 1,450 EFORL BEAUTY WCIG GROUP CLINIC SIAM SNAIL Revenue (MB.)** Y2015 Y2014 COSMETIC 837% 2,587 276 9 WCI **See Page No.63, EFORL AUDITED REPORT 2015 Thai Version

INDUSTRY OVERVIEW 10

FORECAST GDP GROWTH Sources : 2014 2015F 1 2016F 1 2015F 2 2016F 2 2015F 3 2016F 3 1/ Bank of Thailand 2/ World Bank GDP 0.9 3.0 4.1 3.5 4.0 2.5 3.3 3/ CIMB THAI, Research Office (Oct.6, 2015) 11 Sources : World Bank, retrieved date Oct.08, 2015.

HEALTH CARE INDUSTRY OVERVIEW: LINKAGE WITH GDP PLUS THE AGING SOCIETY TREND  Electricity Gas & Water Supply 9%  Hotel & Restaurants 10%  Public Admins & Social Security 6%  Healthcare 4%  Wholesale & Retail 35%  Transportation 25%  Education 6%  Others 5%  Healthcare industry accounts for approximately 4% of the country’s GDP.  Taking sales into discount, medical device and equipment account for 10% (approx.) of total Healthcare industry, so the total medical device and equipment 12 account for 0.4% of country’s GDP.

KEY FINDINGS  Health expense is directly linked with country’s GDP.  The amount per person on health care spending substantially surges in the middle class. Likewise, the inevitable rise in aging people will directly affect the health industry due to the transition shift in structural changes.  Health promotion on its aim to be the centered among Southeast Asian neighborhoods will be implement from 2014-2018/ 13

GROWTH DRIVERS Healthcare industry possesses a positive outlook given the aging society, coming AEC consolidation, Thailand pinned as a medical hub, and strong growth of medical tourism. Aging Society: The inevitably rising population has led to substantial increase in health care spending. Thailand society demographics tend to change gradually to aging society. Strong growth in Medical Tourism: Medical tourism in Thailand is growing at a yearly Thailand Medical Hub: rate of 16%, while in financial Benefited from government terms the foreign medical campaign and development to services sector is expected to promote medical industry & health make a whopping THB 100 service, Thailand will be highlighted billion by 2015. and reinforced the potential integrative flow of international mainstreams to health service. Thereby, we foresee that Thailand AEC in 2016: The liberalization of the services sector GDP on health sector will increase. under the AEC allows foreign investors to hold more than a 14 70% stake in healthcare sector, leading to increase an efficiency of medical industry.